|Title:||Stabilizers to prevent autoradiolysis of radiolabeled peptides and proteins|
|Abstract:||Gentisic acid and its derivatives substantially inhibit peptide autoradiolysis. Gentisic acid or its derivatives may also be used in combination with other stabilizers such as inositol and ascorbic acid to inhibit autoradiolysis of radiolabeled peptides.|
|Inventor(s):||Deutsch; Edward A. (Maryland Heights, MO), Goedemans; Wilhelmus T. (Bergen, NL), Maria de Jong; Martinus T. (Hoogkarspel, NL), Miller; Kathleen M. (St. Louis, MO), Brodack; James W. (Florissant, MO)|
|Assignee:||Mallinckrodt Medical, Inc. (St. Louis, MO)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Device; Formulation;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.